Navigation Links
Dementia in More Educated Hits Later But Harder
Date:10/23/2007

ions to change the natural history of Alzheimer's disease.

"However, as a practical matter, clinicians need to know the very heterogeneous presentation of dementia," he continued. "Particularly, the persons who are responsible for giving care to elderly people -- family members, parental caregivers and clinicians -- need to know that, in people with a lot of education, it is possible that the disease may progress at a more rapid rate than they would expect to see based on their experiences with other people who may not have had as much reserve."

The study pointed out the need for more research, particularly in the area of biological markers, to track how Alzheimer's and other forms of dementia are progressing.

"By the time people experience cognitive symptoms, there may well be quite a large amount of brain pathology, and once we do get treatments that are able to change the natural history, waiting until symptoms develop, particularly in highly educated people, may be too late to affect the disease process," Hall said. "A lot of people are looking for various biological markers of developing dementia. This, I think, magnifies the importance that that research continue."

More information

The Alzheimer's Association' has a Maintain Your Brain program on keeping your brain healthy.



SOURCES: Charles B. Hall, Ph.D., associate professor, biostatistics, department of epidemiology and population health and department of neurology, Albert Einstein College of Medicine, New York City; Oct. 23, 2007, Neurology


'/>"/>
Copyright©2007 ScoutNews,LLC.
All rights reserved

Page: 1 2

Related medicine news :

1. Midlife obesity linked to risk of dementia
2. Dementia - a global problem
3. Music aids in curing dementia
4. Hobbies prevent dementia
5. Moderate alcohol consumption protects against dementia
6. Alcohol decreases risk of dementia
7. Dementia linked to HIV
8. Stroke and Dementia - a ghastly association
9. Risk of dementia reduced hypertension drugs
10. Consuming fish prevents dementia risk
11. Drinking wine beneficial in dementia
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine News(10 mins):Health News:Ronald McDonald Care Mobile(R) Brings Dental Care to Area Schools 2Health News:Ronald McDonald Care Mobile(R) Brings Dental Care to Area Schools 3Health News:Ronald McDonald Care Mobile(R) Brings Dental Care to Area Schools 4Health News:Securities Class Action Filed by Shepherd, Finkelman, Miller & Shah, LLP on Behalf of Hemispherx Biopharma Securities Purchasers Between February 18, 2009 and November 2, 2009 2Health News:Securities Class Action Filed by Shepherd, Finkelman, Miller & Shah, LLP on Behalf of Hemispherx Biopharma Securities Purchasers Between February 18, 2009 and November 2, 2009 3Health News:Securities Class Action Filed by Shepherd, Finkelman, Miller & Shah, LLP on Behalf of Hemispherx Biopharma Securities Purchasers Between February 18, 2009 and November 2, 2009 4Health News:Shoppers Cautioned Against Poisoning With Holiday Gifts 2Health News:Shoppers Cautioned Against Poisoning With Holiday Gifts 3Health News:Shoppers Cautioned Against Poisoning With Holiday Gifts 4Health News:New study finds low rate of injuries at overnight summer camp 2Health News:DNA Test May Detect Immune Disorder in Infants 2
Breaking Medicine Technology:AMP Receives $1.4 Million Grant From the Bill & Melinda Gates Foundation to Improve Advocacy for VACCINES and Immunization Systems in West Africa 2AMP Receives $1.4 Million Grant From the Bill & Melinda Gates Foundation to Improve Advocacy for VACCINES and Immunization Systems in West Africa 3BMP Sunstone Announces the Inclusion of Seventy Eight Drugs in China's National Insurance Catalog 2BMP Sunstone Announces the Inclusion of Seventy Eight Drugs in China's National Insurance Catalog 3Final Data from Phase 2 Study Confirm High Response Rate of Micromet's Blinatumomab in Patients with Acute Lymphoblastic Leukemia 2Final Data from Phase 2 Study Confirm High Response Rate of Micromet's Blinatumomab in Patients with Acute Lymphoblastic Leukemia 3Final Data from Phase 2 Study Confirm High Response Rate of Micromet's Blinatumomab in Patients with Acute Lymphoblastic Leukemia 4IUPUI chemists develop Distributed Drug Discovery 3A Finding drugs for neglected diseases 48927 1IUPUI chemists develop Distributed Drug Discovery 3A Finding drugs for neglected diseases 48927 2IUPUI chemists develop Distributed Drug Discovery 3A Finding drugs for neglected diseases 48927 3Newborn weights affected by environmental contaminants 48923 1Following the dietary guidelines may slow heart disease in women 8834 1